ESG Viewpoint: The cost of gender disparity in Asian companies
We’ve been engaging with 26 of Asia’s most influential companies on this topic.
Global Sustainable Outcomes Q4 2023
From an AI explosion to excitement around obesity treatments, there were a number of structural investment themes that supported stronger-than-expected earnings growth across several holdings within the CT Sustainable Outcomes Global Equity strategy.
Investment conclusions from 2023’s clean energy sell-off
The clean energy index had a tough 2023, but we believe there was an overreaction in markets that didn’t appreciate the nuance of the energy transition.
ESG Viewpoint: Investing in a Just Transition
It’s essential we consider the social dimension as we transition to a low carbon world. We explore the investment implications of a Just Transition.
CT UK Social Bond Fund outcomes report 2023 – transport and communications infrastructure
The Fund invests in this outcome class to improve transport and communications infrastructure across the UK.
CT UK Social Bond Fund impact report 2023 – education, learning and skills
Supporting wider participation in higher education with a focus on promoting social mobility.
UK Social Bond Fund outcomes report 2023 – Affordable housing and property
The shortage of affordable housing is still a critical issue for the sector.
CT UK Social Bond Fund – Foreword 2023
Welcome to our 2023 CT UK Social Bond Fund Annual Impact Report.
ESG Viewpoint: Interpreting climate data for investment portfolios
Climate change and the energy transition will impact the long-term performance of investment portfolios. Here we look at how investors should interpret climate data for managing investment portfolios.
ESG Viewpoint: Diversity in clinical trials
Despite a clear scientific and commercial imperative, a significant gap between patient and trial populations persists. We explain why diversity in clinical trials matters to investors and explore our engagement with companies.
